Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I

被引:102
作者
Boshoff, HI
Mizrahi, V
Barry, CE
机构
[1] NIAID, Tuberculosis Res Sect, Rockville, MD 20852 USA
[2] Univ Witwatersrand, South African Inst Med Res, Mol Mycobatericol Res Unit, Johannesburg, South Africa
[3] Univ Witwatersrand, Sch Pathol, Johannesburg, South Africa
关键词
D O I
10.1128/JB.184.8.2167-2172.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The effects of low extracellular pH and intracellular accumulation of weak organic acids were compared with respect to fatty acid synthesis by whole cells of Mycobacterium tuberculosis and Mycobacterium smegmatis. The profile of fatty acids synthesized during exposure to benzoic, nicotinic, or pyrazinoic acids, as well as that observed during intracellular hydrolysis of the corresponding amides, was not a direct consequence of modulation of fatty acid synthesis by these compounds but reflected the response to inorganic acid stress. Analysis of fatty acid synthesis in crude mycobacterial cell extracts demonstrated that pyrazinoic acid failed to directly modulate the fatty acid synthase activity catalyzed by fatty acid synthase I (FAS-I). However, fatty acid synthesis was irreversibly inhibited by 5-chloro-pyrazinamide in a time-dependent fashion. Moreover, we demonstrate that pyrazinoic acid does not inhibit purified mycobacterial FAS-I, suggesting that this enzyme is not the immediate target of pyrazinamide.
引用
收藏
页码:2167 / 2172
页数:6
相关论文
共 43 条
  • [1] Bloch K, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P1
  • [2] Purification, gene cloning, targeted knockout, overexpression, and biochemical characterization of the major pyrazinamidase from Mycobacterium smegmatis
    Boshoff, HIM
    Mizrahi, V
    [J]. JOURNAL OF BACTERIOLOGY, 1998, 180 (22) : 5809 - 5814
  • [3] Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides
    Boshoff, HIM
    Mizrahi, V
    [J]. JOURNAL OF BACTERIOLOGY, 2000, 182 (19) : 5479 - 5485
  • [4] Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
    Cole, ST
    Brosch, R
    Parkhill, J
    Garnier, T
    Churcher, C
    Harris, D
    Gordon, SV
    Eiglmeier, K
    Gas, S
    Barry, CE
    Tekaia, F
    Badcock, K
    Basham, D
    Brown, D
    Chillingworth, T
    Connor, R
    Davies, R
    Devlin, K
    Feltwell, T
    Gentles, S
    Hamlin, N
    Holroyd, S
    Hornby, T
    Jagels, K
    Krogh, A
    McLean, J
    Moule, S
    Murphy, L
    Oliver, K
    Osborne, J
    Quail, MA
    Rajandream, MA
    Rogers, J
    Rutter, S
    Seeger, K
    Skelton, J
    Squares, R
    Squares, S
    Sulston, JE
    Taylor, K
    Whitehead, S
    Barrell, BG
    [J]. NATURE, 1998, 393 (6685) : 537 - +
  • [5] INHIBITION BY PYRAZINAMIDE OF TUBERCLE-BACILLI WITHIN CULTURED HUMAN MACROPHAGES
    CROWLE, AJ
    SBARBARO, JA
    MAY, MH
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 134 (05): : 1052 - 1055
  • [6] EVIDENCE THAT VESICLES CONTAINING LIVING, VIRULENT MYCOBACTERIUM-TUBERCULOSIS OR MYCOBACTERIUM-AVIUM IN CULTURED HUMAN MACROPHAGES ARE NOT ACIDIC
    CROWLE, AJ
    DAHL, R
    ROSS, E
    MAY, MH
    [J]. INFECTION AND IMMUNITY, 1991, 59 (05) : 1823 - 1831
  • [7] Cynamon MH, 1998, ANTIMICROB AGENTS CH, V42, P462
  • [8] ACTIVITY AND PENETRATION OF ANTITUBERCULOSIS DRUGS IN MOUSE PERITONEAL-MACROPHAGES INFECTED WITH MYCOBACTERIUM-MICROTI OV254
    DHILLON, J
    MITCHISON, DA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) : 1255 - 1259
  • [9] EFFICACY OF INTERMITTENT PYRAZINAMIDE IN EXPERIMENTAL MURINE TUBERCULOSIS
    DICKINSON, JM
    MITCHISON, DA
    [J]. TUBERCLE, 1991, 72 (02): : 110 - 114
  • [10] GROSSET J, 1980, CLIN CHEST MED, V1, P231